EB240920P7500
- 3.15
- 0.000.00%
Eventbrite Newsroom
Are Investors Undervaluing Eventbrite, Inc. (NYSE:EB) By 49%?
Enigma Biomedical - USA Announces Collaboration With Alamar Biosciences to Advance the Field of Diagnostics for Neurodegenerative Diseases
United States Conference, Concert and Event Market Report and Company Analysis 2024-2032 Featuring Mixhalo, Live Nation, Ticket City, Bizzabo, Eventbrite, InEvent, Maritz, and Creative Group
Eventbrite Inc (EB) CTO Vivek Sagi Sells 75,000 Shares
Tonix Stock Jumps on Collaboration for Mpox Vaccine Candidate
'The Beverly Hillbillies, the Musical' Benefits AIDS Taskforce of Greater Cleveland
Eventbrite Shares Are Trading Higher After the Company Announced That It Engaged in Repurchase Transactions for of Its 5.00% Convertible Senior Notes.
Express News | Eventbrite: Sees to Repurchase $120 Mln in Aggregate Principal Amount of 2025 Notes for Aggregate Cash Consideration of About $120.2 Mln
Eventbrite Announces Repurchase of a Portion of Its Existing 5% Convertible Senior Notes Due 2025
Things Look Grim For Eventbrite, Inc. (NYSE:EB) After Today's Downgrade
These Analysts Just Made A Huge Downgrade To Their Eventbrite, Inc. (NYSE:EB) EPS Forecasts
KeyBanc Downgrades Eventbrite to Sector Weight From Overweight
Eventbrite, Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
Eventbrite Second Quarter 2024 Earnings: Revenues Miss Expectations
Earnings Call Summary | Eventbrite(EB.US) Q2 2024 Earnings Conference
Eventbrite, Inc. (EB) Q2 2024 Earnings Call Transcript
Ismael Cala Supports Female Empowerment in Days to Shine
Eventbrite Price Target Maintained With a $7.00/Share by BWS Financial
Buy Rating Maintained for Eventbrite Amid Strategic Adjustments and Valuation Upside
Eventbrite Is Maintained at Buy by B. Riley Securities